Safely Extending Treatment in Alveolar Soft Part Sarcoma
People with alveolar soft part sarcoma can receive immunotherapy treatment for an extended period without long-term side effects.
Author:
Thomas Celona
People with alveolar soft part sarcoma can receive immunotherapy treatment for an extended period without long-term side effects.
The spring 2026 issue of Cancer Today included articles about using AI chatbots, cancer survivor—and “Survivor” winner—Ethan Zohn, and...
Cancer Today's winter 2025-2026 issue covers delaying stem cell transplants in multiple myeloma, new treatments for brain metastases, and...
Cancer Today's fall issue features articles on the early integration of palliative care for blood cancer patients, accommodating deaf...
The AACR hosted a Virtual Patient Advocate Forum in July 2025 on technology’s role in cancer care.
Cancer Today's 2025 summer issue covers the expanded use of neoadjuvant immunotherapy, PSMA-targeted therapy for prostate cancer, and more.
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he...
Cancer Today's Winter 2024-25 issue covers the benefits of stereotactic body radiation therapy, geriatric assessment in cancer care, and...
When Corrie Painter was diagnosed with angiosarcoma, an aggressive cancer in cells that line blood and lymph vessels, in...
Highlights from Cancer Today's summer 2024 issue, including treatment-induced heart conditions, profile of Brian Jones, and more.